Lornoxicam tablets bulk supplier for pharma manufacturers

Lornoxicam Tablets 4 mg, 8 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets

Available Strengths: 4 mg, 8 mg

Reference Brands: Xefo (EU)

Category: Analgesic

Lornoxicam inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis responsible for pain and inflammation. Benefits include rapid, effective relief from acute pain, inflammation, and rheumatologic conditions. It offers anti-inflammatory, analgesic effects with a favorable safety profile when used appropriately.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Lornoxicam tablets are approved in the EU for managing pain and inflammation, regulated by EMA with dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, lornoxicam is not approved and is not marketed. In the EU, brands like Xefo (by Orion) are supported by comprehensive clinical data, with ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for lornoxicam tablets, ensuring adherence to European standards for safe, effective pain management, helping you navigate complex regulatory pathways seamlessly.

Lornoxicam Tablets — third party manufacturing & bulk supply

Lornoxicam Tablets 4 mg, 8 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lornoxicam Tablets is supplied as Oral Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lornoxicam Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lornoxicam Tablets →

Back to Listing

Frequently Asked Questions

Lornoxicam is used to relieve pain, inflammation, and swelling in conditions such as osteoarthritis, rheumatoid arthritis, and postoperative or acute musculoskeletal pain.

Lornoxicam is made from the active ingredient lornoxicam, an oxicam-class non-steroidal anti-inflammatory drug (NSAID), along with standard pharmaceutical excipients based on the manufacturer’s formulation.

Common trade names include Xefo and Lornoxicam (regional branded generics).

Lornoxicam is manufactured by several pharmaceutical companies globally, including manufacturers in the EU, UK, and other regulated markets.

The generic name is lornoxicam.

Well-known brand names include Xefo and various regional branded generics.

It is manufactured in multiple countries worldwide, including regions across Europe, the UK, and other approved global pharmaceutical manufacturing locations.